Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Alfieri

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Rheumatology (Oxford, England)|February 5, 2017
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosisAlarico Ariani, Mario Silva, Valeria Seletti, et al.
RMD Open|March 20, 2019
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosisAlarico Ariani, Mario Silva, Elena Bravi, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Rheumatology (Oxford, England)|February 5, 2017
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosisAlarico Ariani, Mario Silva, Valeria Seletti, et al.
RMD Open|March 20, 2019
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosisAlarico Ariani, Mario Silva, Elena Bravi, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
Pageof 3